Category: Nachrichten

Filtern nach
Ursula Gerhards
31 Mai 2023

Analog Pharma und Dipharma geben die Genehmigung der US FDA für einen abgekürzten Antrag auf ein neues Medikament (ANDA) für 20 mg generische Nitisinon-Kapseln (Temperaturstabil) bekannt.

Princeton, NJ and Chiasso, Switzerland, May 31st, 2023 | Analog Pharma (member of Duchesnay Pharmaceutical Group, hereafter “Analog”) and Dipharma S.A. (“Dipharma”) is pleased to announce that their 20 mg nitisinone abbreviated new drug applicatio...
Gerd Grebing
18 Oktober 2022

Dipharma SA wird als eines der besten Unternehmen der Schweiz für 2022 ausgezeichnet

Chiasso, September 15th, 2022 | Dipharma SA, a specialty pharmaceutical company specialized in high quality and improved medicines for rare diseases, has been recently recognized as one of the best places to work for in Switzerland. During the ass...
Gerd Grebing
10 Oktober 2022

Besuchen Sie unseren Stand im Rahmen der APS in Kassel

Visit us at our booth at the APS from 19.10.-21.10.2022 in Kassel, Germany, we are looking forward to meet you there.
Dipharma SA
8 März 2021

Interview mit PharmaBoardRoom

Founder & CEO Marc-Olivier Geinoz discusses why the company has chosen the largely unexplored rare diseases generics space and the opportunities in metabolic diseases. Marc-Olivier Geinoz – CEO, Dipharma SA Dipharma SA is a Swiss specialty pha...